4-APB

4-(2-Aminopropyl)benzofuran (4-APB) is a monoamine releasing agent and novel designer drug of the benzofuran family.^{[3][4][5][2][1]} It acts as a serotonin–norepinephrine–dopamine releasing agent (SNDRA).^[1][2] The drug was first detected, in Europe, by 2011.^[3]

4-APB

Clinical data
Other names	4-(2-Aminopropyl)benzofuran; 4-APB
Drug class	Serotonin–norepinephrine–dopamine releasing agent[1][2]
Identifiers
IUPAC name 1-(1-benzofuran-4-yl)propan-2-amine
CAS Number	286834-83-1
PubChem CID	10130546
ChemSpider	8306061
UNII	BXL47QK09N
CompTox Dashboard (EPA)	DTXSID901043369
Chemical and physical data
Formula	C11H13NO
Molar mass	175.231 g·mol−1
3D model (JSmol)	Interactive image
SMILES CC(CC1=C2C=COC2=CC=C1)N
InChI InChI=1S/C11H13NO/c1-8(12)7-9-3-2-4-11-10(9)5-6-13-11/h2-6,8H,7,12H2,1H3 Key:XROLBZOMVNMIFN-UHFFFAOYSA-N

See also

• Substituted benzofuran